ARMO BioSciences, Inc. (ARMO) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 30 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jun 22, 2018 involved a transaction of 409,547 shares valued at $20.5M.
No significant insider buying has been recorded for ARMO in the recent period.
No significant insider selling has been recorded for ARMO in the recent period.
Based on recent SEC filings, insider sentiment for ARMO is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at ARMO BioSciences, Inc. (ARMO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ARMO stock, having executed 30 transactions in the past 90 days. The most active insider is Beth C. Seidenberg (Executive), who has made 2 transactions totaling $213.3M.
Get notified when executives and directors at ARMO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 22, 2018 | L. Gordon Carl | Executive | Tender | 409,547 | $50.00 | $20.5M | Large |
| Jun 22, 2018 | L. Gordon Carl | Executive | Tender | 3,709,356 | $50.00 | $185.5M | Large |
| Jun 22, 2018 | C. Seidenberg Beth | Executive | Tender | 4,266,683 | $50.00 | $213.3M | Large |
| Jun 22, 2018 | Cui Xiangmin | Executive | Tender | 1,214,700 | $50.00 | $60.7M | Large |
| Jun 22, 2018 | Associates, Llc Kpcb Xiv | Executive | Tender | 4,266,683 | $50.00 | $213.3M | Large |
| Jun 22, 2018 | Gp IV Llc Orbimed Capital | Executive | Tender | 3,709,356 | $50.00 | $185.5M | Large |
| Jun 22, 2018 | Gp IV Llc Orbimed Capital | Executive | Tender | 409,547 | $50.00 | $20.5M | Large |
| Jun 22, 2018 | Peter Van Vlasselaer | Executive | Tender | 809,865 | $50.00 | $40.5M | Large |
| Jun 22, 2018 | Xu Stella | Executive | Tender | 404,900 | $50.00 | $20.2M | Large |
| Jan 30, 2018 | Gp, L.p. Gv 2016 | Executive | Conversion | 607,350 | $N/A | $0 | |
| Jan 30, 2018 | Caufield &. Byers Xiv, Llc Kleiner Perkins | Executive | Conversion | 4,266,683 | $N/A | $0 | |
| Jan 30, 2018 | Cui Xiangmin | Executive | Conversion | 1,214,700 | $N/A | $0 | |
| Jan 30, 2018 | L.p. Gv 2014, | Executive | Conversion | 607,350 | $N/A | $0 | |
| Jan 30, 2018 | Xu Stella | Executive | Conversion | 404,900 | $N/A | $0 | |
| Jan 30, 2018 | C. Seidenberg Beth | Executive | Conversion | 4,266,683 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 9 | $960.0M | 100.0% |
Conversion(C) | 21 | $0 | 0.0% |
Insider activity at ARMO BioSciences, Inc. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.13 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Beth C. Seidenberg, has transacted $213.3M during this period.